BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 283 filers reported holding BIONTECH SE in Q2 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $814,800 | +0.7% | 7,500 | 0.0% | 0.02% | 0.0% |
| Q2 2023 | $809,475 | -65.8% | 7,500 | -60.5% | 0.02% | -69.5% |
| Q1 2023 | $2,365,709 | -87.4% | 18,991 | -84.8% | 0.06% | -77.7% |
| Q4 2022 | $18,732,134 | +125.5% | 124,698 | +102.4% | 0.26% | +69.9% |
| Q3 2022 | $8,307,000 | -18.4% | 61,600 | -9.7% | 0.16% | -35.5% |
| Q2 2022 | $10,180,000 | +118.1% | 68,249 | +149.3% | 0.24% | +171.9% |
| Q1 2022 | $4,668,000 | -5.2% | 27,373 | +43.4% | 0.09% | -11.9% |
| Q4 2021 | $4,922,000 | +189.4% | 19,091 | +206.3% | 0.10% | -4.7% |
| Q3 2021 | $1,701,000 | +642.8% | 6,232 | +509.2% | 0.11% | +2020.0% |
| Q2 2021 | $229,000 | – | 1,023 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |